The other point I would make here is that in the 4th line dataset, the majority of the censored points are well past the median PFS for 4th line placebo (~2 months).
Doesn't absolve the dataset from a lack of reliability, but if one is fairly comfortable with the placebo response in 4th line GIST then it looks decent imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.